EUVIMEDObjevte EUVIMED
Crossref

Minimum Effective Duration of Laryngopharyngeal Reflux Disease Treatment: A Prospective Study

Jérôme R Lechien

Otolaryngology–Head and Neck Surgery · 2024

DOI: 10.1002/ohn.878 ↗

At a glance

Journal article in Otolaryngology–Head and Neck Surgery, 2024. Written by Jérôme R Lechien. Institution: Department of Otolaryngology-Head and Neck Surgery, Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelin…. Major MEDLINE topics: Laryngopharyngeal Reflux, Proton Pump Inhibitors. Cited 8 times so far (Crossref); 32 references. Funded by: Vesale & Roi Baudouin Foundations.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

To investigate the minimum therapeutic duration for patients with primary laryngopharyngeal reflux disease (LPRD) through the evaluation of symptom changes at multiple time points. Study Design Prospective uncontrolled.

Setting

University medical center.

Methods

Patients with LPRD at the 24‐hour hypopharyngeal‐esophageal multichannel intraluminal impedance‐pH monitoring were recruited from the European Reflux Clinic. Depending on the type of LPRD, patients were treated with a combination of proton‐pump inhibitors, alginate, or magaldrate. Symptoms were evaluated with the reflux symptom score (RSS) at baseline and throughout treatment (1‐, 3‐, 6‐, and 9‐month posttreatment). The most appropriate therapeutic duration was determined using the RSS changes. Signs were evaluated with the reflux sign assessment.

Results

A total of 159 patients completed the study. The mean age was 49.9 ± 15.7 years. At 1‐month posttreatment, 97 patients (61.0%) were considered as early responders to treatment, and the treatment was stopped for 52 patients (32.7%). Of the 62 early nonresponders, 34 patients (21.4%) reached responded to treatment after 3 to 9 months. The cumulative therapeutic success rate at 1‐month posttreatment (61.0%) progressively increased to reach a range of 82.4% to 99.3% at 9‐month posttreatment. The RSS mainly decreased in the first month of treatment in early responders. In early nonresponders, RSS progressively decreased throughout the 9‐month treatment period. The baseline severity of RSS is a strong predictor of therapeutic response.

Conclusion

A therapeutic regimen of 1 month can be sufficient to treat one third of LPRD patients. The early nonresponders may require 3 to 9 months of treatment.

Subjects

MeSH terms (MEDLINE)

Laryngopharyngeal RefluxProton Pump InhibitorsHumansProspective StudiesFemaleMaleMiddle AgedTreatment OutcomeAdultEsophageal pH MonitoringAlginatesDuration of TherapyTime FactorsAged

Author keywords

durationgastroesophagealhead neck surgerylaryngeallaryngologylaryngopharyngealotolaryngologyrefluxsignssymptomstreatment

Substances

Proton Pump InhibitorsAlginates

Authors and institutions

  • Department of Otolaryngology-Head and Neck Surgery, Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France.
  • Department of Otolaryngology, Polyclinic of Poitiers, Elsan Hospital, Poitiers, France.
  • Department of Human Anatomy and Experimental Oncology, Faculty of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.
  • Department of Otolaryngology-Head and Neck Surgery, CHU Saint-Pierre (CHU de Bruxelles), Brussels, Belgium.

Funding

  • Vesale & Roi Baudouin Foundations

Cite

APA

Lechien, J. R. (2024). Minimum Effective Duration of Laryngopharyngeal Reflux Disease Treatment: A Prospective Study. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.878

Vancouver

Lechien JR. Minimum Effective Duration of Laryngopharyngeal Reflux Disease Treatment: A Prospective Study. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.878

BibTeX
@article{Lechien2024,
  author = {Lechien, Jérôme R},
  title = {Minimum Effective Duration of Laryngopharyngeal Reflux Disease Treatment: A Prospective Study},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2024},
  doi = {10.1002/ohn.878}
}
Start for free →